From: Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
Study | Country | Number of alleles (cases/controls) | ϵ2 allele (controls) | ϵ3 allele (controls) | ϵ4 allele (controls) |
---|---|---|---|---|---|
Garlepp et al.[84] | Australia | 28/344 | 0.07 (0.061) | 0.69 (0.811) | 0.29 (0.128) |
Harrington et al.[86] | UK | 22/116 | 0 (0.086) | 0.818 (0.767) | 0.182 (0.147) |
Love et al.[87] | UK | 82/5008 | 0.05 (0.08) | 0.79 (0.79) | 0.16 (0.13) |
Askanas et al.[85] | USA | 22/70 | 0.09 (0.10) | 0.86 (0.79) | 0.05 (0.11) |
Gossrau et al.[51] | Germany | 70/112 | 0.1 (0.036) | 0.757 (0.848) | 0.143 (0.116) |
Needham et al.[48] | Australia | 114/344 | 0.044 (0.061) | 0.825 (0.811) | 0.132 (0.128) |
Present study (our unpublished data)* | UK, USA and two European countries | 116/1540 | 0.07 (0.13) | 0.77 (0.73) | 0.16 (0.14) |